Amkay Products Ltd Stock Price Today (NSE: AMKAY)
Fundamental Score
Amkay Products Ltd Share Price — Live NSE/BSE Price, Fundamentals & Analysis
Amkay Products Ltd share price today is ₹55.50, up +0.00% on NSE/BSE as of 19 June 2026. Amkay Products Ltd (AMKAY) is a Small-cap company in the Medical Equipment & Supplies sector with a market capitalisation of ₹39.82 (Cr). The 52-week high for AMKAY share price is ₹81.99 and the 52-week low is ₹39.22. At a P/E ratio of 11.44x, AMKAY is currently trading below its industry average P/E of 47.87x. The company has a Return on Equity (ROE) of 14.79% and a debt-to-equity ratio of 0.07.
Amkay Products Ltd Share Price Chart — NSE/BSE Historical Performance
Amkay Products Ltd share price chart: 7.02% return over the past month. 52-week high ₹81.99, 52-week low ₹39.22.
Amkay Products Ltd — Last 10 Trading Days
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| ₹55.50 | ₹55.50 | ₹55.50 | ₹55.50 | 2.00K (Cr) | |
| ₹55.50 | ₹55.50 | ₹53.11 | ₹55.50 | 8.00K (Cr) | |
| ₹56.25 | ₹58.00 | ₹55.05 | ₹57.45 | 22.00K (Cr) | |
| ₹61.50 | ₹61.50 | ₹61.00 | ₹61.00 | 6.00K (Cr) | |
| ₹63.00 | ₹63.00 | ₹63.00 | ₹63.00 | 2.00K (Cr) | |
| ₹59.00 | ₹61.00 | ₹59.00 | ₹61.00 | 4.00K (Cr) | |
| ₹54.26 | ₹60.00 | ₹54.26 | ₹60.00 | 14.00K (Cr) | |
| ₹58.00 | ₹58.00 | ₹55.53 | ₹55.53 | 24.00K (Cr) | |
| ₹59.50 | ₹59.50 | ₹54.00 | ₹54.00 | 12.00K (Cr) | |
| ₹59.99 | ₹59.99 | ₹59.99 | ₹59.99 | 2.00K (Cr) |
Amkay Products Ltd — Last 12 Months Price History
| Month | Open | High | Low | Close | Change |
|---|---|---|---|---|---|
| ₹55.50 | ₹55.50 | ₹53.11 | ₹55.50 | +0.00% | |
| ₹57.00 | ₹63.00 | ₹54.00 | ₹57.45 | +0.79% | |
| ₹57.20 | ₹62.90 | ₹55.55 | ₹55.55 | -2.88% | |
| ₹59.66 | ₹59.66 | ₹52.00 | ₹52.00 | -12.84% | |
| ₹65.50 | ₹65.50 | ₹55.10 | ₹62.80 | -4.12% | |
| ₹58.70 | ₹79.85 | ₹56.00 | ₹68.47 | +16.64% | |
| ₹45.10 | ₹81.99 | ₹44.85 | ₹61.75 | +36.92% | |
| ₹50.00 | ₹50.00 | ₹46.00 | ₹46.00 | -8.00% | |
| ₹45.51 | ₹46.98 | ₹39.22 | ₹46.98 | +3.23% | |
| ₹51.78 | ₹54.00 | ₹47.01 | ₹47.01 | -9.21% | |
| ₹56.70 | ₹56.70 | ₹50.55 | ₹54.50 | -3.88% | |
| ₹52.00 | ₹67.00 | ₹49.00 | ₹58.50 | +12.50% |
AI Research Briefing
Powered by Gemini · 2026-04-22
Micro-cap medical device maker with negative free cash flow and reliance on government tenders; liquidity risk is high.
WHAT'S HAPPENING NOW (last 2-4 weeks)
No major catalysts found after live search. The company announced a trading window closure from April 1, 2026, until 48 hours after the declaration of FY26 financial results.
CORE STORY (THE REAL GAME)
Amkay is a play on the growth of the Indian medical devices and disposables market, specifically riding the consumables wave. Not a high-tech innovator, but a low-cost manufacturer benefiting from import substitution and increasing healthcare penetration in Tier-2/3 cities.
- Favorable industry dynamics in Indian medical devices market
- Low P/E relative to industry
- Government push for domestic manufacturing
- Significant order wins from private hospitals
- Successful expansion into export markets
- Improvement in free cash flow generation
- Micro/SME cap equals liquidity risk
- Negative free cash flow of ₹7.28 Cr over 5 years
- Widened net loss in H1 2025 despite revenue growth
Promoter holding high at 73.44%, but no change in FII/DII activity.
India's medical device sector is projected to reach US$50 billion by 2030, a significant tailwind.
No major news found after live search.
No, Free Cash Flow 5Y: ₹-7.28 Cr.
If Amkay can improve free cash flow and secure larger orders, it could re-rate. Otherwise, it remains a risky micro-cap play.
Primary Thesis Risk
Illiquidity and negative free cash flow can sink this ship quickly.
For educational purposes only. Not investment advice. Consult a SEBI-registered advisor before investing.
Returns & Performance
Return on Equity (ROE)
Profit generated per ₹1 of shareholder equity
Return on Capital (ROCE)
Returns generated on total capital deployed
Oper. Profit Margin (5Y Avg)
Average operating profit margin over 5 years
Dividend Yield
Annual dividend as % of current share price
Amkay Products Ltd Valuation Check
Price to Earnings (P/E)
Share price ÷ earnings per share. Lower = cheaper
Industry Avg P/E
Average P/E of all peers in this sector
Market Capitalisation
Total market value of all outstanding shares
Growth Engine
Profit Growth (Quarterly YoY)
Net profit growth vs same quarter last year
Revenue Growth (Quarterly YoY)
Revenue growth vs same quarter last year
Revenue Growth (5-Year CAGR)
Compounded annual revenue growth over 5 years
EPS Growth (5-Year CAGR)
Earnings per share growth over 5 years
Net Profit Growth (5-Year CAGR)
Compounded annual net profit growth over 5 years
Balance Sheet Health
Debt to Equity Ratio
Total debt ÷ equity. Below 0.5 = financially healthy
Interest Coverage Ratio
EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably
Free Cash Flow (5-Year Total)
Cash left after capex over 5 years. Positive = self-funded growth
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Amkay Products Ltd Fundamental Analysis & Valuation Benchmarking
Educational evaluation of AMKAY across key market metrics for learning purposes.
Positive Indicators
8 factors identified
Excellent ROCE Performance (16.88%)
Observation: Superior returns on capital employed across business operations.
Analysis: ROCE >15% demonstrates efficient capital deployment and strong operational performance.
Attractive Valuation (P/E: 11.44 vs Industry: 47.87)
Observation: Trading at discount to industry peers.
Analysis: P/E below industry average may present value opportunity.
Strong Revenue Growth (28.98%)
Observation: Healthy sales growth indicates market demand and execution capability.
Analysis: Revenue growth >15% suggests strong market position and growth potential.
Strong Profit Growth Track Record (39.33% CAGR)
Observation: Consistent 5-year profit compound annual growth rate.
Analysis: Profit CAGR >15% demonstrates scalable business model.
Conservative Debt Levels (D/E: 0.07)
Observation: Low leverage provides financial flexibility and reduced risk.
Analysis: Conservative debt structure offers resilience during economic downturns.
Strong Interest Coverage (12.23x)
Observation: Earnings comfortably cover interest obligations.
Analysis: Interest coverage >5x indicates low financial distress risk.
Balanced Promoter Holding (73.44%)
Observation: Optimal balance between promoter control and public float.
Analysis: Promoter holding in 50-75% range provides management alignment.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral.
Analysis: Absence of share pledging eliminates potential forced-selling pressure.
Risk Factors
3 factors identified
Weak Earnings Growth (-55.84% CAGR)
Observation: Below-average 5-year EPS growth performance.
Analysis: Low EPS growth may not keep pace with inflation.
Negative Free Cash Flow (₹-7.28 Cr over 5Y)
Observation: Cash outflows exceed inflows.
Analysis: Negative FCF requires analysis of capital expenditure cycle.
No Dividend Distribution
Observation: Company does not currently pay dividends to shareholders.
Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.
Amkay Products Ltd vs Medical Equipment & Supplies Peers
Peer Comparison - Medical Equipment & Supplies
Compare Amkay Products Ltd with 10 other companies in the same sector
| Company Info | Fundamental | Valuation | Profitability | Financial Health | Growth | Dividend | ||||
|---|---|---|---|---|---|---|---|---|---|---|
Company Company name | Score Bull Run comprehensive fundamental score based on 20+ metrics | Price Current trading price of the stock | Market Cap Total value of all shares in the market | P/E Price per share divided by earnings per share | ROE Net income divided by shareholder equity | ROCE Earnings before interest and tax divided by capital employed | Debt/Eq Total debt divided by total equity | Profit 5Y Average annual profit growth over 5 years | Sales 5Y Average annual sales growth over 5 years | Dividend Annual dividend per share divided by price per share |
Amkay Products LtdAmkay Products ...Selected✓ AMKAY • 544169 | 55.9/100 | ₹55.50₹56 | ₹39.82₹39.82 | 11.44Average 11.4 Average | 14.79%Average 14.79% Average | 16.88%Good 16.88% Good | 0.07Excellent 0.1 Excellent | 39.33%Excellent 39.33% Excellent | 7.77%Good 7.77% Good | 0.00% |
Poly Medicure LtdPoly Medicure L... POLYMED • 531768 | 60.7/100 | ₹1330.30₹1330 | ₹19506.20₹19506.20 | 53.89Average 53.9 Average | 15.77%Good 15.77% Good | 20.08%Excellent 20.08% Excellent | 0.08Excellent 0.1 Excellent | 28.38%Excellent 28.38% Excellent | 19.44%Excellent 19.44% Excellent | 0.18% |
Fischer Medical Ventures LtdFischer Medical... FISCHER • 524743 | 31.7/100 | ₹37.46₹37 | ₹3162.93₹3162.93 | 157.52Average 157.5 Average | 0.70%Poor 0.70% Poor | 1.08%Poor 1.08% Poor | 0.08Excellent 0.1 Excellent | — — | — — | 0.01% |
Laxmi Dental LtdLaxmi Dental Lt... LAXMIDENTL • 544339 | 68.7/100 | ₹243.13₹243 | ₹1488.44₹1488.44 | 57.78Average 57.8 Average | 21.88%Excellent 21.88% Excellent | 19.20%Good 19.20% Good | 0.04Excellent 0.0 Excellent | 57.51%Excellent 57.51% Excellent | 9.81%Good 9.81% Good | 0.00% |
OSEL DEVICES LIMITEDOSEL DEVICES LI... OSELDEVICE • | 42.1/100 | ₹496.70₹497 | ₹1363.11₹1363.11 | 50.06Average 50.1 Average | 30.08%Excellent 30.08% Excellent | 31.14%Excellent 31.14% Excellent | 0.56Good 0.6 Good | — — | — — | 0.00% |
Tarsons Products LtdTarsons Product... TARSONS • 543399 | 13.8/100 | ₹214.98₹215 | ₹1224.98₹1224.98 | 59.58Average 59.6 Average | 4.75%Poor 4.75% Poor | 6.91%Poor 6.91% Poor | 0.63Good 0.6 Good | — — | — — | 0.00% |
60.3/100 | ₹173.00₹173 | ₹633.93₹633.93 | 25.77Average 25.8 Average | 36.78%Excellent 36.78% Excellent | 31.12%Excellent 31.12% Excellent | 0.53Good 0.5 Good | 90.06%Excellent 90.06% Excellent | 61.82%Excellent 61.82% Excellent | 0.00% | |
Prevest Denpro LtdPrevest Denpro ... PREVEST • 543363 | 68.5/100 | ₹408.00₹408 | ₹521.17₹521.17 | 26.18Average 26.2 Average | 18.74%Good 18.74% Good | 25.25%Excellent 25.25% Excellent | 0.00Excellent 0.0 Excellent | 29.49%Excellent 29.49% Excellent | 22.80%Excellent 22.80% Excellent | 0.23% |
HSIL LimitedHSIL Limited... HSIL • 543916 | 61.2/100 | ₹413.00₹413 | ₹354.57₹354.57 | 34.23Average 34.2 Average | 13.58%Average 13.58% Average | 16.35%Good 16.35% Good | 0.43Excellent 0.4 Excellent | 74.11%Excellent 74.11% Excellent | 13.69%Good 13.69% Good | 0.00% |
47.7/100 | ₹187.00₹187 | ₹294.37₹294.37 | 32.71Average 32.7 Average | 13.56%Average 13.56% Average | 18.45%Good 18.45% Good | 0.01Excellent 0.0 Excellent | — — | — — | 0.00% | |
Nureca LtdNureca Ltd... NURECA • 543264 | 36/100 | ₹272.15₹272 | ₹292.61₹292.61 | 71.19Average 71.2 Average | -1.12%Poor -1.12% Poor | -0.90%Poor -0.90% Poor | 0.03Excellent 0.0 Excellent | — — | 1.98%Average 1.98% Average | 0.00% |
Top Medical Equipment & Supplies Stocks
View all →By Bull Run Score
By Return on Equity
By Market Cap
- Poly Medicure Ltd share price19506.20 Cr
- Fischer Medical Ventures Ltd share price3162.93 Cr
- Laxmi Dental Ltd share price1488.44 Cr
- OSEL DEVICES LIMITED share price1363.11 Cr
- Tarsons Products Ltd share price1224.98 Cr
Amkay Products Ltd PE Ratio History
Historical price-to-earnings ratio for AMKAY — last 5 years
| Year | EPS (₹) | Price (₹) | P/E Ratio |
|---|---|---|---|
| FY 2024 | ₹3.04 | ₹62.66 | 20.6x |
P/E = year-end price ÷ diluted EPS from annual filings. Source: NSE/BSE via Bull Run.
Amkay Products Ltd Quarterly Performance
Latest quarterly metrics for AMKAY — revenue growth and profit growth vs same quarter last year
Revenue Growth (YoY)
28.98%
Latest quarter vs same quarter previous year
Net Profit Growth (YoY)
7.65%
Latest quarter net profit vs same quarter previous year
5-Year Revenue CAGR
7.77%
Compounded annual revenue growth over 5 years
5-Year Profit CAGR
39.33%
Compounded annual net profit growth over 5 years
Amkay Products Ltd Technical Indicators
SMA 50, SMA 200, RSI and volume signals for AMKAY — calculated from daily price history
Momentum is balanced — neither overbought nor oversold.
Technical indicators are for educational purposes only. Not investment advice.
Amkay Products Ltd Financial Statements
Annual income statement, balance sheet and cash flow for Amkay Products Ltd (AMKAY) — sourced from NSE/BSE filings.
Loading Financial Statements...
Fetching financial data for Amkay Products Ltd
About AMKAY (Amkay Products Ltd)
Amkay Products Ltd is a dynamic player in the Indian medical equipment and supplies market, dedicated to enhancing healthcare accessibility and quality through its diverse product ...offerings. The company strategically focuses on manufacturing, assembling, and distributing essential medical devices and consumables that cater to a wide range of healthcare needs. From diagnostic tools to personal protective equipment, Amkay strives to provide reliable and cost-effective solutions for both healthcare professionals and individual consumers. With a commitment to innovation and quality assurance, Amkay Products Ltd aims to be a trusted partner in supporting a healthier India. Amkay Products boasts a comprehensive catalogue designed to meet the diverse demands of the modern healthcare landscape. Their product range encompasses items crucial for infection control, such as a variety of masks, sterilization materials, and protective apparel. Moreover, Amkay offers an array of diagnostic and monitoring equipment, empowering healthcare providers with the tools necessary for accurate assessments and patient care. The company also addresses the needs of home healthcare, providing products that enable individuals to manage their health conditions effectively in the comfort of their own homes. By consistently expanding and refining its offerings, Amkay Products Ltd strives to remain at the forefront of the medical supply industry. Driven by a vision of improving healthcare outcomes across India, Amkay Products Ltd emphasizes ethical business practices and a customer-centric approach. They maintain a strong focus on quality control throughout their manufacturing processes to ensure that all products meet stringent regulatory standards. Amkay's distribution network is strategically designed to reach a broad customer base, enabling them to deliver essential medical supplies efficiently and reliably. Through ongoing research and development, Amkay Products Ltd is committed to introducing innovative solutions that address emerging healthcare challenges and contribute to the overall well-being of the Indian population.
Company Details
Key Leadership
Latest News
AMKAY Share Price: Frequently Asked Questions
What is the current share price of Amkay Products Ltd?
Amkay Products Ltd (AMKAY) trades at ₹55.50 on NSE and BSE. Market cap ₹39.82 (Cr). Educational data only.
What is the P/E ratio of Amkay Products Ltd?
Amkay Products Ltd has a P/E of 11.44x vs industry average 47.87x.
What is the Bull Run score for Amkay Products Ltd?
Amkay Products Ltd has a Bull Run score of 55.9/100 based on 25+ financial parameters.
Does Amkay Products Ltd pay dividends?
Amkay Products Ltd has a dividend yield of 0.00%. Past dividends don't guarantee future payments.
What is the ROE of Amkay Products Ltd?
Amkay Products Ltd has ROE of 14.79%. Higher ROE indicates better use of shareholder equity.
What is the debt-to-equity ratio of Amkay Products Ltd?
Amkay Products Ltd has debt-to-equity of 0.07.
Is Amkay Products Ltd a good investment?
Bull Run gives Amkay Products Ltd a score of 55.9/100. This is not investment advice — consult a SEBI-registered advisor.